AbbVie Newsroom

AbbVie Analyst Ratings

Benzinga07:45 ET

Leerink Partners Upgrades AbbVie to Outperform From Market Perform, Price Target Is $206

MT Newswires06:35 ET

Leerink Partners Upgrades AbbVie(ABBV.US) to Buy Rating, Announces Target Price $206

Moomoo News06:31 ET

Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $195

Moomoo NewsNov 19 03:38 ET

Wells Fargo Adjusts Price Target on AbbVie to $195 From $205, Maintains Overweight Rating

MT NewswiresNov 18 10:46 ET

Redburn Atlantic Adjusts AbbVie's Price Target to $216 From $215, Keeps Buy Rating

MT NewswiresNov 15 12:44 ET

AbbVie Analyst Ratings

BenzingaNov 15 05:10 ET

Wolfe Research Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $205

Moomoo NewsNov 14 16:31 ET

AbbVie Initiated With an Outperform at Wolfe Research

TipRanksNov 14 16:13 ET

Deutsche Bank Adjusts Price Target on AbbVie to $177 From $180, Keeps Hold Rating

MT NewswiresNov 14 07:04 ET

AbbVie Is Maintained at Overweight by JP Morgan

Dow JonesNov 13 10:10 ET

AbbVie Analyst Ratings

BenzingaNov 13 10:03 ET

J.P. Morgan Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $200

Moomoo NewsNov 13 07:32 ET

AbbVie Hold Rating Maintained Amid Emraclidine Trial Challenges and Competitive Pressure

TipRanksNov 13 02:11 ET

UBS Maintains AbbVie(ABBV.US) With Hold Rating, Cuts Target Price to $181

Moomoo NewsNov 12 14:32 ET

AbbVie Is Maintained at Buy by Citigroup

Dow JonesNov 12 14:08 ET

BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $208

Moomoo NewsNov 12 09:35 ET

AbbVie Is Maintained at Overweight by Morgan Stanley

Dow JonesNov 12 08:39 ET

AbbVie Analyst Ratings

BenzingaNov 12 08:31 ET

Citi Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $215

Moomoo NewsNov 12 06:35 ET